T. Rowe Price Associates’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $355K | Sell |
|
|||||
|
2024
Q2 | $637K | Sell |
|
|||||
|
2024
Q1 | $18.2M | Sell |
|
|||||
|
2023
Q4 | $84.8M | Sell |
|
|||||
|
2023
Q3 | $58.8M | Buy |
|
|||||
|
2023
Q2 | $65.2M | Buy |
|
|||||
|
2023
Q1 | $60.8M | Sell |
|
|||||
|
2022
Q4 | $66.6M | Buy |
|
|||||
|
2022
Q3 | $74.1M | Sell |
|
|||||
|
2022
Q2 | $79.1M | Buy |
|
|||||
|
2022
Q1 | $87.4M | Buy |
|
|||||
|
2021
Q4 | $145M | Buy |
|
|||||
|
2021
Q3 | $121M | Buy |
|
|||||
|
2021
Q2 | $114M | Buy |
|
|||||
|
2021
Q1 | $57.3M | Sell |
|
|||||
|
2020
Q4 | $51.1M | Sell |
|
|||||
|
2020
Q3 | $84.6M | Buy |
|
|||||
|
2020
Q2 | $41.5M | Buy |
|
|||||
|
2020
Q1 | $27.1M | Buy |
|
|||||
|
2019
Q4 | $31.9M | Buy |
|